| |
| |
|
| Insider
Information: |
Dable Habib J |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
104,950 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,202,438 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
104,950 |
|
|
| Total
Value |
$18,202,438 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
CEO and President, Dir... |
2021-07-02 |
98,450 |
2016-12-01 |
0 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
6,500 |
2022-06-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
6,500 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,900 |
3,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-07-02 |
4 |
AS |
$126.69 |
$5,356,354 |
D/D |
(42,186) |
98,450 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-07-02 |
4 |
OE |
$35.04 |
$1,478,197 |
D/D |
42,186 |
140,636 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-07-01 |
4 |
OE |
$35.04 |
$2,025,803 |
D/D |
57,814 |
156,264 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-07-01 |
4 |
AS |
$125.15 |
$7,326,588 |
D/D |
(57,814) |
98,450 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,662 |
98,450 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-01-05 |
4 |
AS |
$120.52 |
$515,774 |
D/D |
(4,258) |
81,788 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2021-01-04 |
4 |
D |
$124.31 |
$407,488 |
D/D |
(3,278) |
86,046 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2020-07-01 |
4 |
AS |
$93.53 |
$4,820,445 |
D/D |
(50,000) |
89,324 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2020-07-01 |
4 |
OE |
$35.04 |
$1,752,000 |
D/D |
50,000 |
139,324 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
22,173 |
89,324 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2020-01-03 |
4 |
AS |
$51.24 |
$191,230 |
D/D |
(3,732) |
67,151 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2019-09-10 |
4 |
AS |
$45.20 |
$254,412 |
D/D |
(5,625) |
70,883 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2019-04-09 |
4 |
AS |
$44.23 |
$332,748 |
D/D |
(7,460) |
76,508 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
17,700 |
83,968 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2019-01-03 |
4 |
AS |
$40.85 |
$84,961 |
D/D |
(1,957) |
66,268 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2018-12-04 |
4 |
AS |
$51.54 |
$671,610 |
D/D |
(12,675) |
68,225 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
80,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,800 |
62,800 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
